BRAINOMIX LIMITED
Get an alert when BRAINOMIX LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-09-30 (in 1y)
Last filed for 2025-12-31
Confirmation statement due
2026-11-24 (in 6mo)
Last made up 2025-11-10
Watchouts
None on the register
Cash
£12M
-9.3% vs 2024
Net assets
£13M
-10.6% vs 2024
Employees
0
Average over period
Profit before tax
—
Period ending 2025-12-31
Net assets
3-year trend · vs Technology median
Accounts
3-year trend · latest reflected 2025-12-31
| Metric | Trend | 2024-01-01 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Turnover | — | — | — | |
| Operating profit | — | — | — | |
| Profit before tax | — | — | — | |
| Net profit | — | -£5,509,916 | -£6,901,423 | |
| Cash | — | £12,776,284 | £11,584,146 | |
| Total assets less current liabilities | — | £15,455,405 | £14,037,707 | |
| Net assets | — | £15,079,622 | £13,478,116 | |
| Equity | £5,737,451 | £15,079,622 | £13,478,116 | |
| Average employees | — | 0 | 0 | |
| Wages | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Menzies LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“With the fundraising activities completed in December 2024 and October 2025, the directors estimate that the current cash flow of the Group will be sufficient to support future planned activities. The directors have confidence that they will be able to maintain sufficient cash or will be able to secure sufficient cash inflow for the Group and Company to continue its activities for the foreseeable future and, in any event, for not less than 12 months from the approval of these financial statements and have therefore prepared the financial statements on a going concern basis.”
Group structure
- BRAINOMIX LIMITED · parent
- Brainomix Europe Limited 100%
- Brainomix USA Inc. 100%
- Brainomix Sweden AB 100%
Significant events
- “The Company raised a further £4.9m in equity through issuance of shares in its Series C extension, completed in October 2025 as it continues to be backed by leading Health tech investors, including Boehringer Ingelheim Venture Fund GmbH, Parkwalk Advisors Ltd and Hostplus, and welcomes Modi Ventures a US based investor in 2025.”
- “On 6 January 2025, the Company issues 7,575 Series C Shares with an aggregate nominal value of £7.58 for total cash proceeds of £99,990.”
- “On 3 November 2025, the Company issued 361,483 Series C shares with an aggregate nominal value of £361.48 for total cash proceeds of £4,771,569.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GRIFFIN, Anna Victoria | Secretary | 2025-09-01 | — | — |
| MEHTA, Khushro Fredoon | Director | 2025-04-01 | Feb 1965 | American |
| PAPADAKIS, Michail, Dr. | Director | 2010-11-02 | Jan 1979 | Greek |
| REUSS, Oliver | Director | 2021-12-03 | Sep 1976 | German |
| PARKWALK ADVISORS LTD | Corporate Director | 2019-08-20 | — | — |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| STRANGE, Melissa Claire | Secretary | 2022-09-09 | 2025-01-17 |
| BALL, David William Dawson | Director | 2018-02-19 | 2019-08-20 |
| BARKER, Andrew Charles | Director | 2014-04-01 | 2024-12-13 |
| JAFFRAY, Mark Thomas | Director | 2014-09-26 | 2021-12-03 |
| KALKBRENNER, Frank Axel, Dr | Director | 2018-02-19 | 2021-12-03 |
| NAYLOR, Ann Jacqueline | Director | 2020-08-01 | 2025-03-31 |
| PEITGEN, Heinz-Otto, Dr | Director | 2020-08-01 | 2024-01-24 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Boehringer Ingelheim Venture Fund Gmbh | Corporate entity | Shares 25–50%, Voting 25–50% | 2021-06-25 | Active |
| Mnl (Parkwalk) Nominees Limited | Corporate entity | Shares 25–50%, Voting 25–50% | 2021-05-21 | Active |
| Dr Michail Papadakis | Individual | Significant influence | 2016-04-06 | Ceased 2021-06-25 |
Filing timeline
Last 20 of 99 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-11-11 RESOLUTIONS Resolution
- 2025-01-06 MA Memorandum articles
- 2025-01-06 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-02 | AA | accounts | Accounts with accounts type group | |
| 2025-11-14 | RP01SH01 | miscellaneous | Legacy | |
| 2025-11-11 | RESOLUTIONS | resolution | Resolution | |
| 2025-11-10 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-11-07 | SH01 | capital | Capital allotment shares | |
| 2025-09-02 | AP03 | officers | Appoint person secretary company with name date | |
| 2025-07-11 | AA | accounts | Accounts with accounts type group | |
| 2025-07-09 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-07-05 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-05-08 | AP01 | officers | Appoint person director company with name date | |
| 2025-05-06 | TM01 | officers | Termination director company with name termination date | |
| 2025-01-20 | SH01 | capital | Capital allotment shares | |
| 2025-01-17 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-01-06 | MA | incorporation | Memorandum articles | |
| 2025-01-06 | RESOLUTIONS | resolution | Resolution | |
| 2025-01-02 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-03 | AA | accounts | Accounts with accounts type small | |
| 2024-07-06 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-06-14 | CH02 | officers | Change corporate director company with change date | |
| 2024-01-30 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 11
- Capital events
- 2
- Officers appointed
- 1
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-12-31 vs 2024-12-31
-
Turnover
—
Not reported
-
Cash
-9.3%
£12,776,284 £11,584,146
-
Net assets
-10.6%
£15,079,622 £13,478,116
-
Employees
—
Not reported
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers